Pieris Pharmaceuticals | 8-K:重大事件
Pieris Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Aquilo Capital, L.P.(1.1%),Aquilo Capital Management, LLC(1.1%)等
Pieris Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Checkpoint Capital (Master) Fund, LP(0%),Checkpoint Capital, LP(0%)等
Pieris Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Lynx1 Capital Management LP(9.9%),Weston Nichols(9.9%)
Pieris Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Soleus Capital Master Fund, L.P.(0.0%),Soleus Capital, LLC(0.0%)等
Pieris Pharmaceuticals | 8-K:重大事件
Pieris Pharmaceuticals:2023财年三季报
Pieris Pharmaceuticals | 8-K/A:重大事件(修正)
Pieris Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(20.8%),BVF Inc.(20.8%)等
Pieris Pharmaceuticals | S-8:员工福利计划证券登记
Pieris Pharmaceuticals | 10-Q:2023财年二季报
Pieris Pharmaceuticals | 8-K:重大事件
Pieris Pharmaceuticals | 8-K:重大事件
Pieris Pharmaceuticals | 8-K:重大事件
Pieris Pharmaceuticals | 4:持股变动声明-董事 Barbier Ann
Pieris Pharmaceuticals | 4:持股变动声明-董事 GERAGHTY JAMES A
Pieris Pharmaceuticals | 4:持股变动声明-董事 Kiener Peter A
Pieris Pharmaceuticals | 4:持股变动声明-董事 KIRITSY CHRISTOPHER P
Pieris Pharmaceuticals | 4:持股变动声明-董事 Richman Michael
Pieris Pharmaceuticals | 4:持股变动声明-董事 Said Maya R.
暂无数据